GSK1265744

Known as: GSK744 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2018
02420122018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
GSK1265744 is a new HIV integrase strand transfer inhibitor (INSTI) engineered to deliver efficient antiviral activity with a… (More)
Is this relevant?
2014
2014
BACKGROUND GSK1265744 (744) is an HIV-1 integrase inhibitor in clinical development as a long-acting (LA) injectable formulation… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
BOSTON — The results from a particular drug trial presented here last month at the annual Conference on Retroviruses and… (More)
Is this relevant?
2014
2014
OBJECTIVE Pharmacokinetics, safety, and tolerability of GSK1265744 (744) and rilpivirine (RPV) (TMC278) were assessed after… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2014
2014
GSK1265744 (GSK744) is an integrase strand-transfer inhibitor that has been formulated as a long-acting (LA) injectable suitable… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Dolutegravir (DTG) and GSK1265744 are HIV integrase inhibitors (INIs) in clinical development. The oral formulation of… (More)
  • table 1
  • table 3
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
BACKGROUND GSK1265744 is an HIV integrase strand transfer inhibitor selected for clinical development. OBJECTIVE This first… (More)
Is this relevant?
2013
2013
HIV integrase inhibitors such as raltegravir and elvitegravir halt HIV progression, but treatment-emergent resistance and cross… (More)
Is this relevant?
2013
2013
The continuing HIV epidemic has driven advancements in antiretroviral therapy. New therapeutic targets have been identified over… (More)
Is this relevant?
2013
2013
We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?